| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
From the Center for Stroke Research, Department of Neurology (Drs. Tanne, D’Olhaberriague, and Levine, and L. Salowich–Palm and K. Sawaya), and the Department of Biostatistics & Research Epidemiology (Dr. Schultz), Henry Ford Hospital & Health Sciences Center, Detroit Campus of Case Western University, Detroit, MI; and the Department of Neurology (Dr. Tanne), Chaim Sheba Medical Center, Tel Hashomer, Israel.
Address correspondence and reprint requests to Dr. Steven R. Levine, Director WSU/DMC Stroke Program, WSU School of Medicine, University Health Center, 6-E, 4201 St. Antoine, Detroit, MI 48201; e-mail: slevine{at}med.wayne.edu
OBJECTIVE: To investigate associations between cerebrovascular risk factors and anticardiolipin (aCL) immunoreactivity.
BACKGROUND: High titers of aCL immunoreactivity, mainly the immunoglobulin (Ig) G isotype, were shown to predict aCL-related thrombo-occlusive complications.
METHODS: aCL antibodies, and IgG and IgM isotypes were measured by a validated assay in a single laboratory, run in duplicate, in 749 individuals with first ischemic stroke (n = 300) and patients with other CNS disease or undergoing diagnostic procedures.
RESULTS: Age varied according to aCL categories, with a mean of 61.8 years among patients with negative aCL (<10 IgG phospholipid units [GPL]) to 62.3, 64.9, and 69.9 years in patients with immunoreactivity 10 to 20, 20 to 40, and >40 GPL respectively (p = 0.02). History of atrial fibrillation, congestive heart failure, or valvular heart disease was associated with significantly higher rates of positive IgG aCL (>10 GPL) and with higher immunoreactivity. IgG aCL immunoreactivity increased significantly, in a dose–response manner, as a function of the number of cerebrovascular risk factors present. In patients with first ischemic stroke, rates of 10 to 20, 20 to 40, and >40 GPL were 14%, 7%, and 0% among those with no risk factors versus 20%, 12%, and 12% respectively among patients with four or more risk factors (p = 0.007). No significant associations were identified, however, between IgM isotype aCL and any of the risk factors or increasing number of risk factors.
CONCLUSION: The presence of multiple cerebrovascular risk factors is associated with substantially higher rates of positive IgG isotype aCL, and with higher immunoreactivity. These findings should caution against overdiagnosis of the antiphospholipid syndrome, and consequent changes in management among patients with multiple cerebrovascular risk factors.
This article has been cited by other articles:
|
|
 |
|
  S. Quenby, R.G. Farquharson, F. Dawood, A.M. Hughes, and J. Topping Recurrent miscarriage and long-term thrombosis risk: a case-control study Hum. Reprod., June 1, 2005; 20(6): 1729 - 1732. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A Katzav, J Chapman, and Y Shoenfeld CNS dysfunction in the antiphospholipid syndrome Lupus, December 1, 2003; 12(12): 903 - 907. [Abstract] [PDF]
|
|
|
|
|
|
R L Brey, J Chapman, S R Levine, G Ruiz-Irastorza, R H. Derksen, M Khamashta, and Y Shoenfeld Stroke and the antiphospholipid syndrome: consensus meeting Taormina 2002 Lupus, July 1, 2003; 12(7): 508 - 513. [Abstract] [PDF]
|
|
|
|
 |
|
 R. L. Brey, C. L. Stallworth, D. L. McGlasson, M. A. Wozniak, R. J. Wityk, B. J. Stern, M. A. Sloan, R. Sherwin, T. R. Price, R. F. Macko, et al. Antiphospholipid Antibodies and Stroke in Young Women * Editorial Comment Stroke, October 1, 2002; 33(10): 2396 - 2401. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. G. I. Jennekens and L. Kater The central nervous system in systemic lupus erythematosus. Part 2. Pathogenetic mechanisms of clinical syndromes: a literature investigation Rheumatology, June 1, 2002; 41(6): 619 - 630. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. D. Bushnell, Z. Siddiqi, and L. B. Goldstein Improving patient selection for coagulopathy testing in the setting of acute ischemic stroke Neurology, October 9, 2001; 57(7): 1333 - 1335. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. D. Bushnell and L. B. Goldstein Diagnostic Testing for Coagulopathies in Patients With Ischemic Stroke Stroke, December 1, 2000; 31(12): 3067 - 3078. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. J. Kirkham, M. Prengler, D. K.M. Hewes, and V. Ganesan Risk Factors for Arterial Ischemic Stroke in Children J Child Neurol, May 1, 2000; 15(5): 299 - 307. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
